A5063987935- Thyroid Cancer Diagnosis and Treatment
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Neuroblastoma Research and Treatments
- Medical Imaging and Pathology Studies
- Thyroid and Parathyroid Surgery
- MRI in cancer diagnosis
- Ovarian cancer diagnosis and treatment
- Radiation Dose and Imaging
- SARS-CoV-2 and COVID-19 Research
- Prostate Cancer Diagnosis and Treatment
- Parathyroid Disorders and Treatments
- Radiology practices and education
- Lung Cancer Research Studies
- CNS Lymphoma Diagnosis and Treatment
- Advanced X-ray and CT Imaging
- Vaccine Coverage and Hesitancy
- Bladder and Urothelial Cancer Treatments
- Systemic Lupus Erythematosus Research
- Cancer, Hypoxia, and Metabolism
- COVID-19 diagnosis using AI
- NF-κB Signaling Pathways
- Vitamin D Research Studies
Ente Ospedaliero Ospedali Galliera
2018-2024
University of Milan
2018
Universidade de São Paulo
2017
Fondazione Salvatore Maugeri
2016
Istituto Nazionale di Fisica Nucleare, Sezione di Pavia
2015
University of Pavia
2015
Our purpose was to evaluate the diagnostic role of <sup>18</sup>F-3,4-dihydroxyphenylalanine (DOPA) PET/CT at time staging in children with neuroblastoma and investigate its ability assess treatment response. We also investigated prognostic value <sup>18</sup>F-DOPA same points. <b>Methods:</b> enrolled onset. Before after induction chemotherapy, all patients underwent <sup>123</sup>I-metaiodobenzylguanidine (MIBG) scanning plus SPECT/CT. results were compared those <sup>123</sup>I-MIBG...
Molecular imaging of muscle-invasive bladder cancer (MBC) is restricted to its locoregional and distant metastases, since most radiopharmaceuticals have a urinary excretion that limits the visualization primary tumor.
The aim of the present study is to evaluate kinetics and dosimetry 64CuCl2 in human prostate cancer (PCa) lesions. We prospectively evaluated 50 PCa patients with biochemical relapse after surgery or external beam radiation therapy. All underwent 64CuCl2-PET/CT detect recurrence/metastases. Volumes interest were manually drawn for each avid lesion a diameter > 1 cm on mpMRI patient. Time-activity curves all lesions obtained. effective biological half-life standard uptake values (SUVs)...
Background and Objectives: 18F-fluorodeoxyglucose (FDG) positron emission tomography/X-ray computed tomography (PET/CT) represents the mainstay diagnostic procedure for suspected ovarian cancer (OC) recurrence. PET/CT can be integrated with contrast medium in various settings; however, effective benefit of this is still debated. We aimed to compare capabilities low-dose contrast-enhanced (PET/ldCT PET/ceCT) patients relapse. Materials Methods: 122 OC underwent both PET/ldCT PET/ceCT. Two...
Background: mRNA-based vaccines have shown 95% protection from SARS-COV-2 disease in healthy populations. Initial findings cancer patients suggest a lower seroconversion and greater toxicity possibly related to myelo-immunosuppressive therapies.Methods: We conducted prospective study assess factors predicting poor adverse events following immunization (AEFI) the BNT162b2 vaccine on active treatment. The primary endpoint was (IgG<25 AU/mL) after 21 days second dose. Patients who ended...
Journal Article Investigation of radiation-induced multilayered signalling response the inflammatory pathway Get access G. Babini, Babini * 1Dipartimento di Fisica, Universitá degli Studi Pavia, via Bassi 6, I-27100 Italy2Istituto Nazionale Fisica Nucleare (INFN), Sezione Italy *Corresponding author: gabriele.babini@unipv.it Search for other works by this author on: Oxford Academic PubMed Google Scholar M. Ugolini, Ugolini J. Morini, Morini Italy3Dipartimento Medicina Molecolare, Forlanini...
Purpose: the validation of a new scoring model considering principal risk factors differentiated thyroid cancer (DTC) relapse. Methods: we evaluated all DTC patients treated with thyroidectomy and radioactive iodine (RAI) therapy. Three domains were considered: demographic domain (age gender), surgical (histology American Thyroid Association categories), RAI-related (pre-RAI thyroglobulin post-therapeutic 131I whole-body scan). The progression-free survival was assessed. patients’ sample...